Bone Density Values Explained: T-Scores, Z-Scores & What They Mean

·

Share

Your bone density values tell you one critical thing: how likely your bones are to break. A T-score of -2.5 or lower means osteoporosis. A score between -1.0 and -2.5 means osteopenia (thinning bones). And anything above -1.0 is considered normal. These thresholds, established by the World Health Organization, are the foundation of how every doctor evaluates fracture risk.

But a single T-score doesn’t tell the whole story. Your age, sex, fracture history, medication use, and even which bone was scanned all change what that number actually means for you. Here’s a complete breakdown of bone density values and their clinical significance — the same framework I use when interpreting DEXA results in practice.

What Exactly Is a Bone Density Value?

Bone density values come from a Dual-Energy X-ray Absorptiometry (DEXA) scan, which measures how many grams of mineral are packed into a square centimeter of bone (g/cm²). The raw number itself isn’t what matters clinically — it’s how your result compares to reference populations.

That comparison produces two scores:

  • T-score: Compares your bone density to a healthy 30-year-old adult of the same sex (peak bone mass). This is the primary diagnostic score for postmenopausal women and men over 50.
  • Z-score: Compares your bone density to someone your own age, sex, and body size. This is used for premenopausal women, men under 50, and children.

Each unit on the T-score scale represents one standard deviation (SD) from the young-adult mean. A T-score of -2.0 means your bone density is two standard deviations below peak. That translates to roughly a 2–3x increased fracture risk compared to someone with a T-score of 0.

WHO Diagnostic Thresholds: The Numbers That Matter

T-Score Range WHO Classification Approximate Fracture Risk Clinical Action
-1.0 and above Normal Baseline risk Lifestyle optimization, rescreen per guidelines
-1.0 to -2.5 Osteopenia (low bone mass) 1.5–2x baseline FRAX assessment, possible treatment if high risk
-2.5 and below Osteoporosis 2–4x baseline Pharmacological treatment recommended
-2.5 and below + fracture Severe (established) osteoporosis 4–8x baseline Aggressive treatment, fall prevention, specialist referral

One crucial nuance: these thresholds apply specifically to the femoral neck, total hip, and lumbar spine (L1–L4) as measured by central DEXA. Peripheral devices that scan your wrist or heel use different reference databases and shouldn’t be used alone for a formal osteoporosis diagnosis.

T-Score vs. Z-Score: When Each One Matters

If you’re a postmenopausal woman or a man over 50, your doctor will use the T-score to make diagnostic and treatment decisions. The lowest T-score across the hip, femoral neck, and lumbar spine is typically the one that drives the diagnosis.

For premenopausal women, men under 50, and children, the Z-score takes priority. A Z-score of -2.0 or lower is classified as “below expected range for age” and should trigger an investigation for secondary causes — think vitamin D deficiency, celiac disease, hyperparathyroidism, or chronic glucocorticoid use.

A Z-score below -2.0 in a younger patient is a red flag. It means their bones are significantly thinner than their peers, and something beyond normal aging is likely responsible.

FRAX: Why Your T-Score Alone Isn’t Enough

The FRAX tool (Fracture Risk Assessment Tool) calculates your 10-year probability of a major osteoporotic fracture and hip fracture specifically. It combines your femoral neck T-score with clinical risk factors:

  • Age, sex, and BMI
  • Previous fragility fracture
  • Parental history of hip fracture
  • Current smoking
  • Alcohol intake (≥3 units/day)
  • Glucocorticoid use
  • Rheumatoid arthritis
  • Secondary causes of osteoporosis

In the U.S., the National Osteoporosis Foundation recommends pharmacologic treatment when the 10-year hip fracture probability is ≥3% or the 10-year major osteoporotic fracture probability is ≥20%. This means some patients with osteopenia (T-score -1.5, for example) actually need treatment, while some with borderline osteoporosis may not — context is everything.

Who Should Get a DEXA Scan?

Current guidelines from the USPSTF, ISCD, and Endocrine Society recommend screening for:

  • All women aged 65+ and men aged 70+
  • Postmenopausal women under 65 with risk factors (low body weight, smoking, family history of fracture)
  • Adults with a fragility fracture after age 50
  • Anyone on glucocorticoid therapy ≥5 mg prednisone daily for ≥3 months
  • Patients with conditions known to cause bone loss: hyperparathyroidism, celiac disease, type 1 diabetes, chronic kidney disease, rheumatoid arthritis, anorexia nervosa
  • Adults on aromatase inhibitors or androgen deprivation therapy

What Affects DEXA Accuracy?

Several things can falsely elevate or lower your T-score:

  • Degenerative disc disease and spinal arthritis artificially increase lumbar spine values — very common in patients over 65
  • Aortic calcification can inflate spine readings
  • Prior vertebral fractures compress the vertebral body, falsely raising density per area
  • Obesity can introduce beam-hardening artifacts
  • Calcium supplements taken within 24 hours can interfere if fragments are in the scan field

When spine values seem unreliable, the hip becomes the preferred diagnostic site. In some cases, a one-third radius (forearm) DEXA is used as an alternative.

When to See a Doctor

Request a bone density evaluation if any of the following apply:

  • You’re a postmenopausal woman or a man over 50 and have never been screened
  • You’ve had a fracture from a low-impact event (falling from standing height or less)
  • You’ve been on oral steroids for more than 3 months
  • You’ve lost more than 1.5 inches (4 cm) in height
  • You have a first-degree relative who fractured a hip

If you already have a DEXA result and your T-score is between -1.0 and -2.5, ask your doctor to run a FRAX calculation. Many patients in the osteopenia range are told “just take calcium” when they actually meet criteria for bisphosphonate therapy.

Frequently Asked Questions

What T-score qualifies as osteoporosis?

A T-score of -2.5 or lower at the lumbar spine, femoral neck, or total hip on a central DEXA scan meets the WHO definition of osteoporosis. If that low score is accompanied by a fragility fracture, it’s classified as severe osteoporosis.

Can bone density values improve with treatment?

Yes. Bisphosphonates like alendronate typically increase spine BMD by 5–8% over 3 years and hip BMD by 3–6%. Newer agents like denosumab and romosozumab can produce even larger gains. However, a stable T-score on treatment still represents a significant reduction in fracture risk — the goal isn’t just a better number, it’s fewer fractures.

How often should I repeat a DEXA scan?

For most patients on osteoporosis treatment, repeat DEXA every 1–2 years is standard. For untreated patients with normal or mildly low bone density, rescreening every 3–5 years is usually sufficient. The ISCD recommends repeating sooner if there’s a clinical reason — new fracture, starting a bone-toxic medication, or significant weight loss.

Is a Z-score of -1.5 something to worry about?

In isolation, a Z-score of -1.5 is within the expected range for age (the cutoff for concern is -2.0). However, if you’re a 35-year-old with a Z-score of -1.5 and you’ve fractured a bone from minimal trauma, that combination warrants a workup for secondary causes of bone loss — including vitamin D, calcium, PTH, thyroid function, and celiac serology.

Does a normal T-score mean I won’t fracture?

No. About 50% of fractures in postmenopausal women occur in people with T-scores in the osteopenic range, not the osteoporotic range — simply because far more people have osteopenia than osteoporosis. Bone density is one piece of the puzzle. Fall risk, bone quality (which DEXA doesn’t measure), and clinical risk factors all contribute to fracture probability.

Written by
Bone Marrow Biology, Haematology
Contact [email protected] thekinglab WebsiteBaylor College of Medicine July 2, 2020 Inflammatory regulation of hematopoietic stem cells Katherine Y. King MD PhD is Associate Professor of Pediatric Infectious Diseases at Baylor College of Medicine, where she is part of the faculty for the Stem Cells and Regenerative Medicine Center and serves as a co-director of the BCM MSTP. Her research focuses…
View Full Profile →
Web Admin Avatar